2
Participants
Start Date
January 3, 2018
Primary Completion Date
September 18, 2020
Study Completion Date
September 18, 2020
Alphanate
Bolus IV injection.
A.O.U. Santa Maria della Misericordia Perugia, Perugia
University of North Carolina at Chapel Hill, Hemophilia and Thrombosis Center, Chapel Hill
Hospital Universitario La Paz, Madrid
Emory University, Atlanta
University of Kentucky, Lexington
Hospital Universitario Virgen del Rocio, Seville
Hospital Universitari i Politecnic La Fe, Valencia
Azienda Ospedaliera Universitaria Careggi, Florence
Childrens Hospital and Clinics of Minnesota, Minneapolis
The Childrens Mercy Hospital, Kansas City
Seattle Children's Hospital, Seattle Children's Research Institute, Seattle
Center for Hemophilia Treatment St.-Petersburg, Saint Petersburg
Lokmanya Tilak Municipal Medical College & General Hospital, Mumbai
B. J. Govt. Medical College & Sassoon Hospital, Pune
FGUs Hospital - Kirov Scientific Research Institute, Kirov
Kemerovo Regional Clinical Hospital, Kemerovo
Robert Wood Johnson Medical Group, New Brunswick
Newark Beth Israel Medical Center & Children's Hospital of New Jersey, Newark
McMaster Children's Hospital, Hamilton
Universita degli Studi di Roma La Sapienza, Roma
Lead Sponsor
Grifols Biologicals, LLC
INDUSTRY
Grifols Therapeutics LLC
INDUSTRY